AbbVie (NYSE:ABBV) has entered into a license deal with Danish biotech Gubra A/S to develop the latter’s experimental obesity ...
New recommendations for addressing obesity without judgment can help clinicians conduct productive, non-stigmatizing weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback